NCT01885091

Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial Photodamage

Kinerase® Interactive Skin-care Study: A Multicentre, Phase IV, Single-arm, Open-label Trial to Evaluate the Efficacy and Safety of Kinetin, N6-furfuryladenine, 0.1% for Treatment of Cutaneous Facial Photodamage

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Menarini (Thailand) Limited · Industry
• Sex: All
• Age: 35 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the K.I.S.S. study is to evaluate the efficacy of Kinerase® Cream (Kinetin 0.1%) in Thai patients, on the basis of the severity and clinical signs of facial photodamage.

Conditions

• Skin Roughness
• Mottling
• Blotchiness
• Pigmentation
• Fine Wrinkles

Interventions

Type	Name	Description
OTHER	Kinerase

Timeline

• Start date: 2012-12-01
• Primary completion: 2013-03-01
• First posted: 2013-06-24
• Last updated: 2013-06-25

Locations

1 site across 1 country: Thailand